The scientist is devoted to studying duplicators

The scientist is devoted to studying duplicators
Phoenix's news: The research institute of Rosling of Britain announced a few days ago, should cultivate the nucleus transplantation technology of duplicating many jasmines of sheep, have already been awarded the patent formally by the British patent office. This is that duplication technology with broad application prospect obtains patent protection for the first time, it has initiated the new dispute regarding how in Britain to utilize the patented method to promote new developing biological medical treatment to study correctly. Rosling research institute say though research institute announce in the world utilizing adult the intersection of animal and the intersection of body and cell duplicate, succeed in large jasmines of lamb for the first time will it be will it be twenty four February 1997, but duplicated the technology that sheep used they have already studied for many yearsed. Duplicate sheep's technology and obtain the patent for the first time. As far back as the end of August of 1995, the research institute put forward the patent application about nucleus transplantation technology on beginning the British patent office. Two parts approved were 17 in term of a patent, involved nucleus transplantation technology separately, and utilize various that this technology cultivate to duplicate products. The patent application in U.S.A. of this technology has already got the recognition of the American patent office too, and expected to obtain approval within several months of future. The research institute of Rosling relied on nucleus transplantation technology on July 5, 1996, utilize adult animal's body cells to duplicate out many jasmine sheep in the world for the first time. In order to develop the commercial use which duplicates technology, the research institute of Rosling established the biomedical company of Rosling at the beginning of 1998, this company is bought by the outstanding grand company of Silicon Valley of U.S.A. subsequently, become the outstanding grand company subordinate's subsidiary, the company renames as ' the outstanding grand biomedical company ' subsequently too. Technology is monopolized and hinders development. It is reported, though the patent of nucleus transplantation technology belongs to the research institute of Rosling, Britain's biotechnology and biological study council and British agriculture, fishery and three of grain state affairs department own together, but ' outstanding grand biomedical company ' will have right to employ this patent exclusively worldwide. According to the permission agreement of the patent, besides two fields, the outstanding grand company will have the right to develop various uses of nucleus transplantation technology. These two fields duplicate studying for human reproduction respectively, and foster the transgenic animal containing the medicine in the milk. They permit belonging to Britain PPL medical company in world-wide exclusive application. Some personages think, because the exclusive application right of this patent belongs to the American company, this pair of biological industries of Britain are happiness or anxiety still too difficult to expect. And the view shows, duplicating the technical patent is monopolized by a company, may give and develop the medical treatment which duplicate technology and employ and bring limiting too.

|